Patents by Inventor Tapan Kanti Das

Tapan Kanti Das has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8722622
    Abstract: The present invention provides a FGF21 molecule covalently attached to the combining site of an antibody via a linker, wherein the linker is covalently attached to the side chain of a linking residue within FGF21. Various uses of the compounds are provided, including methods to prevent or treat diabetes or diabetes-related conditions.
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: May 13, 2014
    Assignees: COVX Technologies Ireland, Limited, Pfizer Inc.
    Inventors: Tapan Kanti Das, Tamara Shafer Hodge, Tetsuya Ishino, Nancy Jane Levin, Moorthy Sitharamaiah Suriyanarayana Palanki, Erin Kristen Parsons, Bernard Norman Violand
  • Publication number: 20120282279
    Abstract: The present invention provides a FGF21 molecule covalently attached to the combining site of an antibody via a linker, wherein the linker is covalently attached to the side chain of a linking residue within FGF21. Various uses of the compounds are provided, including methods to prevent or treat diabetes or diabetes-related conditions.
    Type: Application
    Filed: November 4, 2011
    Publication date: November 8, 2012
    Applicants: COVX TECHNOLOGIES IRELAND LIMITED, PFIZER INC
    Inventors: Tapan Kanti Das, Tamara Shafer Hodge, Tetsuya Ishino, Nancy Jane Levin, Moorthy Sitharamaiah Suriyanarayana Palanki, Erin Kristan Parsons, Bernard Norman Violand
  • Publication number: 20090238820
    Abstract: The present invention relates to anti-MAdCAM antibody compositions comprising a chelating agent, and methods of treating inflammatory disease in a subject.
    Type: Application
    Filed: March 2, 2006
    Publication date: September 24, 2009
    Inventors: Corey M. Allan, Tapan Kanti Das, Scott Steven Ganser, Sandeep Nema, Satish K. Singh, David Li Zeng